MedPath

Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension

Not Applicable
Conditions
Hypertension Complicating Pregnancy, Childbirth, and the Puerperium
Chronic Hypertension With Pre-Eclampsia
Hypertension in Pregnancy
Preeclampsia
Gestational Hypertension
Interventions
Behavioral: Remote blood pressure monitoring
Behavioral: Usual Care
Registration Number
NCT05457504
Lead Sponsor
Massachusetts General Hospital
Brief Summary

Cardiovascular disease and hypertensive disorders of pregnancy (HDP) are the leading causes of maternal morbidity and mortality in the United States. Postpartum, in office care has demonstrated to be an insufficient model of hypertensive management postpartum, largely due to barriers that women face in accessing in office care, with stark racial disparities in access. The care of postpartum patients with HDP following delivery is made up of either a single postpartum visit at 6 weeks postpartum or a fragmented and non-standardized series of in-person appointments depending on the patients' medical complications and the clinicians' experience. Further, current society guidelines outline inpatient thresholds for initiation of antihypertensive medication but do not provide recommendations for titration thereafter. The proposed study will investigate the acceptability and effectiveness of an algorithm-based, outpatient treatment model for the management of postpartum hypertension utilizing an asynchronous text-based platform as compared to the standard of care for postpartum women with a diagnosis of Hypertensive disorder of pregnancy at Massachusetts General Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Age >18 years
  • Diagnosis of gestational hypertension (Systolic Blood Pressure (SBP)≥140 or Diastolic Blood Pressure (DBP) ≥90 on at least two occasions at least 4 hours apart after 20 weeks gestation in previously normotensive women) and or preeclampsia (SBP≥140 or DBP ≥90, proteinuria with or without symptoms of preeclampsia (headache, vision changes, right upper quadrant pain), and presentation of symptoms/lab abnormalities but no proteinuria)
  • English and Spanish-speaking
  • Delivering at Massachusetts General Hospital
Exclusion Criteria
  • Chronic hypertension or underlying cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalRemote blood pressure monitoring-
Usual CareUsual Care-
Primary Outcome Measures
NameTimeMethod
Percent of patients who are normotensive at 6 weeks postpartum by American College of Cardiology (ACC)/American Heart Association (AHA) guidelines6 weeks

Percent of patients who are normotensive at 6 weeks postpartum by ACC/AHA guidelines (\>130/80) in each treatment group

Secondary Outcome Measures
NameTimeMethod
Adherence with scheduled outpatient clinical appointments6 months

Percent of scheduled outpatient clinical appointments attended by patients in the first 6 postpartum months in each treatment group

Establishment of care with a primary care doctor1 year

Percent of patients who attend a primary care doctor visit in the first postpartum year in each treatment group

Frequency of Hospital readmission6 weeks

Frequency of Hospital readmission in the first 6 weeks postpartum in each treatment group

Percent of patients who are normotensive at 6 weeks postpartum by American College of Obstetricians and Gynecologists (ACOG) guidelines6 weeks

Percent of patients who are normotensive at 6 weeks postpartum by ACOG guidelines (\>140/90) in each treatment group

Number of medication titrations6 weeks

Mean number of medication titrations by patient in the first 6 postpartum weeks in each treatment group

© Copyright 2025. All Rights Reserved by MedPath